MICROENCAPSULATION USING POLY (L-LACTIC ACID) .3. EFFECT OF POLYMER MOLECULAR-WEIGHT ON THE MICROCAPSULE PROPERTIES

被引:34
作者
JALIL, R [1 ]
NIXON, JR [1 ]
机构
[1] UNIV LONDON,KINGS COLL LONDON,CHELSEA DEPT PHARM,LONDON SW3 6LX,ENGLAND
关键词
D O I
10.3109/02652049009028422
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Poly L-lactic acid microcapsules were prepared using an emulsification and organic solvent evaporation technique w/o system with phenobarbitone as a reference core. Three polymers of different molecular weight 61 300; 43 200, 2400 were used to prepare different core loaded microcapsules. Microcapsule size increased with increase in polymer molecular weight. Microcapsule size was also found to increase with increase in core loading with the two high molecular weight polymers, whilst the low molecular weight polymer tended to aggregate to form larger microcapsules than expected. The calculated microcapsule density was found to decrease with an increase in the polymer molecular weight and core loading. 'Encapsulation efficiency> was reduced with the decrease in initial theoretical core loading. However, the phenobarbitone content of the microcapsules was not affected by the difference in polymer molecular weight. Significant morphological differences were observed due to variations in the polymer molecular weight. The two high molecular weight polymers were found to produce non-uniform, porous microcapsules, whilst low molecular weight polymer formed a uniform non-porous surface when core loading was low. With increasing core loading, an increasing number of phenobarbitone crystals were observed on the surface and microcapsules became increasingly porous. This was more evident after release of the drug. Differential scanning calorimetry of the microcapsules showed thermal events for both the polymer and phenobarbitone. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:41 / 52
页数:12
相关论文
共 15 条
  • [1] Beck L.R., Cowsar D.R., Lewis D.H., Cosgrove R.J., Riddel C.T., Lowry S.L., Epperly T., A new long acting injectable microcapsule system for administration of progesterone, Fertility and Sterility, 31, 5, (1979)
  • [2] Beck L.R., Ramos R.A., Flowers C.E., Lopez G.Z., Lewis D.H., Cowsar D.R., Clinical evaluation of injectable biodegradable contraceptive system, American Journal of Obstetrics and Gynecology, 140, pp. 799-806, (1981)
  • [3] Benoit J.P., Benita S., Puisieux F., Thies C., Davis S.S., Ilium L., McVie J.G., Tomlinson E., Stability and release kinetics of drugs incorporated within microspheres, Microspheres and Drug Therapy. Pharmaceutical, Immunological and Medical Aspects, pp. 91-102, (1984)
  • [4] Bopmeier R., McGinity J.W., The preparation and evaluation of drug containing poly(D, L-lactide) microspheres formed by the solvent evaporation, Pharmaceutical Research, 4, pp. 465-471, (1987)
  • [5] Fong J.W., Maulding H.V., Visscher G.E., Nazareno J.P., Pearson J.E., Lee P., Good W.R., Enhancing drug release from (lactide) microspheres by using base in the microencapsulation process, Controlled Release Technology. Pharmaceutical Applications, pp. 214-231, (1987)
  • [6] Jackanicz T.M., Nash H.A., Wise D.L., Gregory J.B., Polylactic acid as a biodegradable carrier for contraceptive steroids, Contraception, 8, pp. 227-234, (1973)
  • [7] Jalil R., Nixon J.R., Microencapsulation using poly (L-lactic acid). I: Microcapsule properties affected by the preparative technique, Journal of Microencapsulation, 6, 4, pp. 473-484, (1989)
  • [8] Jalil R., Nixon J.R., Microencapsulation using poly (L-latic acid). II: Preparative variables affecting microcapsule properties, Journal of Microencapsulation, 7, 1, pp. 25-39, (1990)
  • [9] Kulkarni R.K., Pani K.C., Neuman C., Leonard F., Polylactic acid for surgical implants, Archives of Surgery, 93, pp. 839-843, (1966)
  • [10] Mason N.S., Thies C., Cicero T.J., In Vivo and in vitro evaluation of a microencapsulated narcotic antagonist, Journal of Pharmaceutical Sciences, 65, pp. 847-850, (1976)